Comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study

被引：4
|
作者：
Demb, HB [1 ]
Roychoudhury, K [1 ]
机构：
[1] Albert Einstein Coll Med, Rose F Kennedy Univ Affiliated Program, Childrens Evaluat & Dev Ctr, Bronx, NY 10461 USA
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2000年 / 20卷 / 05期
关键词：
D O I：
10.1097/00004714-200010000-00016
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：580 / 581
页数：2
相关论文
共 50 条
  • [1] Reply to comments on "Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study"
    Potenza, MN
    McDougle, CJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2001, 21 (02) : 246 - 247
  • [2] Olanzapine treatment of children, adolescents, and adults with pervasive developmental disorders: An open-label pilot study
    Potenza, MN
    Holmes, JP
    Kanes, SJ
    McDougle, CJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1999, 19 (01) : 37 - 44
  • [3] Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study
    McDougle, CJ
    Holmes, JP
    Bronson, MR
    Anderson, GM
    Volkmar, FR
    Price, LH
    Cohen, DJ
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (05): : 685 - 693
  • [4] Open-label study of olanzapine in children with pervasive developmental disorder
    Kemner, C
    Willemsen-Swinkels, SHN
    de Jonge, M
    Tuynman-Qua, H
    van Engeland, H
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2002, 22 (05) : 455 - 460
  • [5] Open-label memantine in children and adolescents with pervasive developmental disorders
    Posey, David J.
    Erickson, Craig A.
    Stigler, Kimberly A.
    Mullett, Jennifer
    McDougle, Christopher J.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2006, 16 (06) : 653 - 653
  • [6] Low-Dose Fluvoxamine Treatment of Children and Adolescents with Pervasive Developmental Disorders: A Prospective, Open-Label Study
    Andrés Martin
    Kathleen Koenig
    George M. Anderson
    Lawrence Scahill
    Journal of Autism and Developmental Disorders, 2003, 33 : 77 - 85
  • [7] Low-dose fluvoxamine treatment of children and adolescents with pervasive developmental disorders: A prospective, open-label study
    Martin, A
    Koenig, K
    Anderson, GM
    Scahill, L
    JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2003, 33 (01) : 77 - 85
  • [8] Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation
    Brodkin, ES
    McDougle, CJ
    Naylor, ST
    Cohen, DJ
    Price, LH
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1997, 7 (02) : 109 - 121
  • [9] Sertraline in adults with pervasive developmental disorders: A prospective open-label investigation
    McDougle, CJ
    Brodkin, ES
    Naylor, ST
    Carlson, DC
    Cohen, DJ
    Price, LH
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1998, 18 (01) : 62 - 66
  • [10] An open-label trial of escitalopram in pervasive developmental disorders
    Owley, T
    Walton, L
    Salt, J
    Guter, SJ
    Winnega, M
    Leventhal, BL
    Cook, EH
    JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 2005, 44 (04): : 343 - 348
12345